Status:

COMPLETED

Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression

Lead Sponsor:

University of Parma

Conditions:

Glaucoma, Open-Angle

Eligibility:

All Genders

19-85 years

Brief Summary

The aim of this study was to evaluate the lymphocyte phenotype in primary open- angle glaucoma (POAG) patients compared to healthy subjects of the same age, in order to confirm the importance of immun...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of primary open-angle glaucoma
  • age between 19 an 85 years old

Exclusion

  • age less than 19 or more than 85 yrs
  • positive history for (a) neurodegenerative diseases, (b) autoimmune diseases, (c) cancer, (d) viral infection and (e) diabetes, (f)systemic inflammation

Key Trial Info

Start Date :

June 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2008

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00981422

Start Date

June 1 2007

End Date

June 1 2008

Last Update

September 22 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Azienda ospedaliera universitaria

Parma, Italy, 43100

Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression | DecenTrialz